Antibiotic Regimens for Community-Acquired Pneumonia in Pediatric Patients

Introduction to Antibiotic Therapy

The American Academy of Pediatrics recommends amoxicillin as the first-line treatment for outpatient management of community-acquired pneumonia in pediatric patients, with macrolides recommended for atypical pathogens, while hospitalized patients require age-appropriate parenteral therapy based on likely pathogens 1, 2

For penicillin-allergic patients, the Infectious Diseases Society of America recommends oral clindamycin (40 mg/kg/day in 3 doses) as an alternative 1, 3

The Pediatric Infectious Diseases Society recommends ampicillin or penicillin G for fully immunized children with no risk factors for resistant organisms, and ceftriaxone (50-100 mg/kg/day every 12-24 hours) or cefotaxime (150 mg/kg/day every 8 hours) for children with incomplete immunization or in areas with high prevalence of resistant pneumococci 1, 2
For methicillin-susceptible S. aureus, the Infectious Diseases Society of America recommends cefazolin (150 mg/kg/day every 8 hours) or oxacillin (150-200 mg/kg/day every 6-8 hours) 1, 4
For methicillin-resistant S. aureus (MRSA) susceptible to clindamycin, the Infectious Diseases Society of America recommends vancomycin (40-60 mg/kg/day every 6-8 hours) or clindamycin (40 mg/kg/day every 6-8 hours) 1, 3

For Streptococcus pneumoniae, the American Academy of Pediatrics recommends amoxicillin as the drug of choice for outpatient treatment, and for parenteral therapy: ampicillin or penicillin G for susceptible strains; ceftriaxone or cefotaxime for resistant strains 1, 2
For Mycoplasma pneumoniae/Chlamydophila pneumoniae, the Infectious Diseases Society of America recommends azithromycin as the preferred agent (dosing: 10 mg/kg on day 1, followed by 5 mg/kg/day once daily on days 2-5) 1, 2
For Haemophilus influenzae, the American Academy of Pediatrics recommends amoxicillin (75-100 mg/kg/day in 3 doses) for β-lactamase negative strains, and amoxicillin-clavulanate (amoxicillin component 45-90 mg/kg/day) for β-lactamase producing strains 1, 2

The Infectious Diseases Society of America recommends completing a total 5-day course for uncomplicated CAP, and for complicated pneumonia or specific pathogens like S. aureus, longer courses may be needed 1, 2

The American Academy of Pediatrics recommends limiting antibiotic exposure whenever possible to minimize development of resistance 2
The Infectious Diseases Society of America recommends using the proper dosage to achieve minimal effective concentration at the infection site 2